<DOC>
	<DOC>NCT00802828</DOC>
	<brief_summary>Compare the rate and extent of absorption of famotidine 40 mg tablets, administered as 1 x 40 mg tablet under fasting conditions.</brief_summary>
	<brief_title>Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Famotidine</mesh_term>
	<criteria>healthy men or women 18 years of age or older body mass index below 30.0 kg/m2 willing to participate and sin a copy of the informed consent form recent history of drug or alcohol addiction or abuse pregnant or lactating women history of allergic response to heparin, famotidine, other H2receptor antagonists, or other related drugs evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant recipient of any drugs as part of a research study within 30 days prior to study dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>bioavailability</keyword>
	<keyword>famotidine</keyword>
</DOC>